暂无分享,去创建一个
Hiroto Hatabu | Krastan B. Blagoev | Tomás Boril | Jan Rusz | Tereza Tykalová | Dana Horáková | Emil Svoboda | Charles R. G. Guttman | Vlad I. Valtchinov | C. Guttmann | J. Rusz | H. Hatabu | T. Tykalová | K. Blagoev | D. Horáková | V. Valtchinov | Emil Svoboda | Tomáš Bořil | T. Bořil
[1] J. Aarseth,et al. Health related quality of life in patients recently diagnosed with multiple sclerosis , 2014, Acta neurologica Scandinavica.
[2] Joseph James Duffy,et al. Clinical and imaging characterization of progressive spastic dysarthria , 2014, European journal of neurology.
[3] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[4] Stephen M. Wilson,et al. Lesion-symptom mapping in the study of spoken language understanding , 2017, Language, cognition and neuroscience.
[5] T. Fog,et al. [Multiple sclerosis; review]. , 1954, Maanedsskrift for praktisk laegegerning og social Medicin.
[6] Roman Cmejla,et al. Distinct patterns of imprecise consonant articulation among Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy , 2017, Brain and Language.
[7] G. Vavougios,et al. An electroglottographical analysis-based discriminant function model differentiating multiple sclerosis patients from healthy controls , 2018, Neurological Sciences.
[8] T. Perera,et al. Speech metrics, general disability, brain imaging and quality of life in multiple sclerosis , 2020, European journal of neurology.
[9] H. Weiner,et al. Ensemble learning predicts multiple sclerosis disease course in the SUMMIT study , 2020, npj Digital Medicine.
[10] Jan Volín,et al. Stability of Prosodic Characteristics Across Age and Gender Groups , 2017, INTERSPEECH.
[11] M. Valis,et al. Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS , 2021, Frontiers in Neurology.
[12] A. Rae-Grant,et al. Diagnosis and Treatment of Multiple Sclerosis: A Review. , 2021, JAMA.
[13] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[14] 竜太 金野,et al. Voxel-based lesion-symptom mapping , 2018 .
[15] J. Rusz,et al. Automated Assessment of Oral Diadochokinesis in Multiple Sclerosis Using a Neural Network Approach: Effect of Different Syllable Repetition Paradigms , 2020, IEEE Transactions on Neural Systems and Rehabilitation Engineering.
[16] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[17] T. Perera,et al. Acoustic Speech Analytics Are Predictive of Cerebellar Dysfunction in Multiple Sclerosis , 2020, The Cerebellum.
[18] B. Murdoch,et al. Multiple Sclerosis: Associated Speech and Language Disorders , 1987 .
[19] L. Palagi,et al. Machine Learning Use for Prognostic Purposes in Multiple Sclerosis , 2021, Life.
[20] Klara Novotna,et al. Characteristics of motor speech phenotypes in multiple sclerosis. , 2018, Multiple sclerosis and related disorders.
[21] L. Ramig,et al. Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders , 2020, Movement disorders : official journal of the Movement Disorder Society.
[22] Max Kuhn,et al. Building Predictive Models in R Using the caret Package , 2008 .
[23] Jan Rusz. Detecting speech disorders in early Parkinson’s disease by acoustic analysis , 2018 .
[24] Lena Hartelius,et al. Prevalence and Characteristics of Dysarthria in a Multiple-Sclerosis Incidence Cohort: Relation to Neurological Data , 2000, Folia Phoniatrica et Logopaedica.
[25] J. Rusz,et al. Brain volumetric correlates of dysarthria in multiple sclerosis , 2019, Brain and Language.
[26] W. Oertel,et al. Speech Biomarkers in Rapid Eye Movement Sleep Behavior Disorder and Parkinson Disease , 2021, Annals of neurology.